S: Streptomycin (25 μg/disc), A Amphotericin BB (10 μg/disc), N.T: Not tested S: Streptomycin, A Amphotericin BB, N.T: Not tested The standard drug streptomycin was active against all reference bacteria (zone of inhibition range: 11.2 24.3 mm; MIC range: 15.6 7.8 μg/ml).
The optical density (OD) of a sample tested (S) was compared with the OD of the positive control (PC) to give an S/P percentage value (ODsample)/ODpositive control × 100).
CoNS = Coagulase-negative Staphylococcus, *Gram negative rods and S. pneumonia, N = number of isolates tested, S = Sensitive, R = Resistant, Oxacilin, Chloramphenical, Erythromycin, Gentamycin, Tetracycline, Ciprofloxacin, Vancomycin, Streptomycin, Polymyxcin-B, Tobramycin.
Our primary analysis compared the effect of the S allele with the L allele on discontinuation, but given the lack of unequivocal data for the 5-HTTLPR genetic model, all models were tested: S allele vs. L allele, S carriers vs. LL, L carriers vs. SS, and SS vs. LL.
This was calculated using the formula: (1) 1 - 1 n n - 1 ) ∑ j = 1 S x j x j - 1 where n is the total number of isolates tested, S the number of different genotypes and xj is the number of isolates belonging to the jth genotype [ 19].
When we tested (S)- 3, we determined a 13 μM IC50 value for the inactivation protocol, a value between that of chimeric compounds (R)- 7–(R)- 10 and (R)- 2. In addition, (R)- 7–(R)- 10 displayed enhanced efficacy over (R)- 2 and (S)- 3 (i.e., the maximal transition to inactivated channel state was increased).
Furthermore, we showed that the lower tested (S -roscovitine doS -roscovitinestronger neuroprotective effects than the high doses suggexhibitedat (strongervitineuroprotectivebiphasic U-shapeffects-response relathanship as frequenthe observed in neuroprotection studies [35].
Among the catalysts tested, (S -BINEPINE 9 afforded the higheS -BINEPINEnd enantioselectivities.
In the presence of all NO and HNO donors tested, S-oxidation rather than S-nitrosylation was the dominant modification of reactive cysteine residues of GSTP1.
BpirSP-39 was capable of hydrolyzing different chromogenic substrates tested S-22222, S-2302, and S-2238) while Cu2+ significantly diminished BspirSP-39 activity on the three tested substrates.
The enzyme possesses high catalytic activity on different chromogenic substrates tested S-22388, S-2222, and S-2302)); however, when incubated with Cu2+, its catalytic activity was diminished significantly on the three tested substrates.
